Sarıcı, A. Et Al. 2021. Efficacy and safety of ruxolitinib plus extracorporeal photopheresis in acute and chronic graft versus host disease: A single center experience. Annals of Medical Research , vol.28, no.11 , 2065-2070.

Sarıcı, A., Erkurt, M. A., Bahçecioğlu, Ö. F., Tanriverdi, L. H., Berber, İ., Kaya, E., ... Biçim, S.(2021). Efficacy and safety of ruxolitinib plus extracorporeal photopheresis in acute and chronic graft versus host disease: A single center experience. Annals of Medical Research , vol.28, no.11, 2065-2070.

Sarıcı, AHMET Et Al. "Efficacy and safety of ruxolitinib plus extracorporeal photopheresis in acute and chronic graft versus host disease: A single center experience," Annals of Medical Research , vol.28, no.11, 2065-2070, 2021

Sarıcı, AHMET Et Al. "Efficacy and safety of ruxolitinib plus extracorporeal photopheresis in acute and chronic graft versus host disease: A single center experience." Annals of Medical Research , vol.28, no.11, pp.2065-2070, 2021

Sarıcı, A. Et Al. (2021) . "Efficacy and safety of ruxolitinib plus extracorporeal photopheresis in acute and chronic graft versus host disease: A single center experience." Annals of Medical Research , vol.28, no.11, pp.2065-2070.

@article{article, author={AHMET SARICI Et Al. }, title={Efficacy and safety of ruxolitinib plus extracorporeal photopheresis in acute and chronic graft versus host disease: A single center experience}, journal={Annals of Medical Research}, year=2021, pages={2065-2070} }